Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers
1 other identifier
interventional
30
1 country
1
Brief Summary
The goal of this clinical trial is to improve quality of life in Parkinson's Disease (PD) patients by increasing their empathy and their (self-)compassion. The main question it aims to answer is: Does the level of quality of life in PD patients and caregivers improve after empathy/(self-)compassion training? Participants will be delivered a 6-week empathy and compassion training (mindfulness, writing and poetry exercises addressing the cognitive, emotional, motivational and behavioural components of (self-)compassion) and will also be asked to answer questionnaires before and after the training
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2025
CompletedFirst Posted
Study publicly available on registry
July 31, 2025
CompletedStudy Start
First participant enrolled
November 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
December 1, 2025
November 1, 2025
1.6 years
July 17, 2025
November 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PD patients quality of life improvement
the change (no min / max values foreseen) in the level of quality of life in PD patients as measured by the Parkinson's Disease Questionnaire (PDQ-8), which assesses 8 domains of quality of life: mobility, activities of daily of living, emotional well-being, stigma, social support, cognition, communication, and bodily discomfort; higher scores indicate a worse quality of life
from baseline to the end of intervention (6weeks)
Secondary Outcomes (4)
change in the level of empathy in PD patients and caregivers
from baseline to the end of intervention (6weeks)
self-compassion level change in PD patients and caregivers
from baseline to the end of intervention (6weeks)
compassion level change in PD patients and caregivers
from baseline to the end of intervention (6weeks)
quality of life level change in caregivers
from baseline to the end of intervention (6weeks)
Study Arms (1)
Empathy and (self-)compassion training
EXPERIMENTALA 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises addressing the cognitive, emotional, motivational and behavioural components of (self-)compassion. The training will be designed in order to address both self-compassion and compassion. We expect to conduct 1 session at the beginning and 1 session at the end of the program with exercises to do at home for 6 weeks, assigned as tasks based on the needs of patients and their caregivers
Interventions
A 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises
Eligibility Criteria
You may qualify if:
- Diagnosis of PD
- Hoehn and Yahr scale, stage ≤ 3
- Mini Mental State Examination with a score ≥ 26
- Able to give informed consent as documented by signature
- At least, secondary school education
- To have a regular caregiver at home
You may not qualify if:
- Any medical condition that is not PD, such as drug induced parkinsonism
- Major depression, dysthymia, or according to DSM-V
- Other neurological or psychiatric diseases
- Neuropsychological scores compatible with the diagnosis of early dementia
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc
- For CAREGIVERS:
- Taking care of the patient on a regular basis, i.e., at least 3 days per week
- Being caregiver of the patients for at least 3 months
- At least, secondary school education
- Written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istituto di Neuroscienze Cliniche della Svizzera Italiana, EOC
Lugano, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. MD PhD
Study Record Dates
First Submitted
July 17, 2025
First Posted
July 31, 2025
Study Start
November 6, 2025
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
December 1, 2025
Record last verified: 2025-11